Evidence map›Paper›PMID 21329682›Full record

ArticleChemico-biological interactions2011

Aldose reductase-mediated induction of epithelium-to-mesenchymal transition (EMT) in lens.

Gregory J Zablocki, Philip A Ruzycki, Michelle A Overturf, Suryanarayana Palla, G Bhanuprakesh Reddy, J Mark Petrash

Abstract read
In one paragraph

Article in Chemico-biological interactions, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Gregory J ZablockiDepartment of Ophthalmology, University of Colorado School of Medicine, Aurora, CO 80045, United States.
Philip A Ruzycki
Michelle A Overturf
Suryanarayana Palla
G Bhanuprakesh Reddy
J Mark Petrash
University of Colorado Denver · USNational Institute of Nutrition · IN

Funding

WASHINGTON UNIVERSITY CENTER VISION RESEARCHP30EY002687 · NEI · WASHINGTON UNIVERSITY · PI Philip Andrew Ruzycki · 1985 to 2026
$18.4M
MOLECULAR BIOLOGY OF ALDOSE REDUCTASE AND CATARACTR01EY005856 · NEI · WASHINGTON UNIVERSITY · PI PETRASH, JONATHAN MARK · 1988 to 2014
$6.8M
Vision Research Training ProgramT35EY021455 · NEI · UNIVERSITY OF COLORADO DENVER · PI PETRASH, JONATHAN MARK, ROSS, RANDAL G · 2011 to 2015
$74k
MOLECULAR STUDIES OF ALDOSE REDUCTASE AND CATARACTR23EY005856 · NEI · EMORY UNIVERSITY · PI PETRASH, JONATHAN MARK · 1985 to 1987
–
MOLECULAR BIOLOGY OF ALDOSE REDUCTASE AND CATARACTR55EY005856 · NEI · WASHINGTON UNIVERSITY · PI PETRASH, JONATHAN MARK · 1991 to 1991
–
NEI NIH HHS EY005856NEI NIH HHS P30 EY002687NEI NIH HHS R01 EY005856NEI NIH HHS T35 EY021455
6 · The paper itself

Abstract

Cataract is a key factor in the morbidity associated with diabetes. While the pathogenesis of diabetic cataract formation is poorly understood, previous research has identified aldose reductase (ALR2) as a key player. To elucidate a potential role for this enzyme in diabetic cataract formation, we created a series of transgenic mice designed for expression of human ALR2 (AKR1B1) in epithelial and outer cortical fiber cells of the lens. One of the founder lines, designated PAR39, developed an early onset cataract that involved formation of a plaque of cells at the anterior aspect of the lens. These cells appear to separate from the anterior epithelium and undergo a dramatic change that is reminiscent of the epithelial to mesenchymal transition (EMT). We characterized this phenotype in the PAR39 strain by examining rates of cell proliferation and by immunostaining for markers of EMT. Incorporation of the thymidine analog bromodeoxyuridine (BrdU) was used to estimate cell proliferation in two functional areas of the lens epithelium: the mitotically active germinative zone (GZ) and the less proliferative center zone (CZ). Staining cell nuclei with diamido 4',6-diamidino-2-phenylindole (DAPI) was used to establish a total cell count in the demarcated areas. Lens epithelium in PAR39 transgenic mice demonstrated a decrease in the percentage of BrdU/DAPI staining within the GZ as compared to nontransgenic littermate controls (8.1% vs. 10.9%). A similar decrease in BrdU/DAPI was observed in the CZ (0.6% compared to 3.3%). However, cell density was greater within the GZ of PAR39 mice as compared with nontransgenic controls, while it was not significantly different in the CZ among the two groups. Furthermore, cells associated with the epithelial plaque did not stain positive for BrdU, but were strongly positive for alpha-smooth muscle actin, a classical marker for EMT. These findings suggest that ALR2 over-expression is associated with an alteration in the balance between proliferation and apoptosis of epithelial cells in the mouse lens, and that cells associated with epithelial plaques in the PAR39 lens have features in common with cells undergoing EMT.

Indexed as

Epithelial-Mesenchymal TransitionAldehyde ReductaseAnimalsBiomarkersCapsule OpacificationCell ProliferationDiabetes ComplicationsEpithelial CellsGene Expression Regulation, EnzymologicHumansLens, CrystallineMiceMice, TransgenicPhenotypeAKR1B1 protein, humanAldehyde ReductaseBiomarkers

Identifiers

PMID21329682
PMCPMC3575513
OpenAlexW1971714432

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.